Pfizer (PFE)

Depreciation & Amortization

$6.58B

TTM · Period ending: · USD

PFE logo

PFE Depreciation & Amortization

Latest reported$6.58B
PFE TTM Depreciation & Amortization ($224.80M → $6.58B)
High-resolution chart · PNG

PFE depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
6,584,000,000
6,587,000,000
6,592,000,000
6,696,000,000
6,789,000,000
6,895,000,000
7,013,000,000
6,892,000,000
6,697,000,000
6,539,000,000
6,290,000,000
6,139,000,000
5,762,000,000
5,364,000,000
5,064,000,000
4,822,000,000
4,980,000,000
5,113,000,000
5,133,000,000
4,902,000,000
4,769,000,000
4,660,000,000
4,619,000,000
4,957,000,000
5,302,000,000
5,631,000,000
6,010,000,000
6,267,000,000
6,328,000,000
6,362,000,000
6,384,000,000
6,317,000,000
6,269,000,000
6,281,000,000
6,269,000,000
6,244,000,000
6,074,000,000
5,887,000,000
5,757,000,000
5,632,000,000
5,508,000,000
5,322,000,000
5,157,000,000
5,064,000,000
5,118,000,000
5,341,000,000
5,537,000,000
5,798,000,000
5,993,000,000
6,195,000,000
6,513,000,000
6,816,000,000
6,951,000,000
6,996,000,000
7,443,000,000
7,918,000,000
8,477,000,000
9,055,000,000
8,938,000,000
8,562,000,000
8,576,000,000
8,540,000,000
8,487,000,000
8,267,000,000
7,007,000,000
5,800,000,000
4,757,000,000
4,161,000,000
4,388,000,000
4,611,000,000
5,090,000,000
5,028,000,000
5,204,000,000
5,416,000,000
5,200,000,000
5,351,000,000
5,311,000,000
5,213,000,000
5,293,000,000
5,459,000,000
5,494,000,000
5,561,000,000
5,576,000,000
5,454,000,000
5,352,000,000
5,198,000,000
5,093,000,000
5,533,000,000
5,373,000,000
5,070,000,000
4,078,000,000
2,552,000,000
1,722,000,000
1,034,000,000
1,036,000,000
1,107,000,000
1,082,000,000
1,085,000,000
1,068,000,000
1,033,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.